Abiopharma

New Form 6-K - GENMAB A/S Filed: 2025-06-18 AccNo: 0001434265-25-000047 Size: 240 KB

New Form 6-K - SOPHiA GENETICS SA Filed: 2025-06-18 AccNo: 0001840706-25-000021 Size: 10 MB

New Form 4 - MESA LABORATORIES INC /CO/ Filed: 2025-06-18 AccNo: 0001228924-25-000008 Size: 10 KB

New Form SCHEDULE 13D/A - AN2 Therapeutics, Inc. Filed: 2025-06-18 AccNo: 0001373604-25-000092 Size: 8 KB

New Form 4 - MESA LABORATORIES INC /CO/ Filed: 2025-06-18 AccNo: 0001228924-25-000007 Size: 10 KB

Three Cancers, One Critical Moment | Wendy Sue Swanson at HUB25

New Form 144 - Varex Imaging Corp Filed: 2025-06-18 AccNo: 0001959173-25-004192 Size: 4 KB

Aptevo Therapeutics Announces $8 Million Offering Priced At-the-Market Under Nasdaq Rules

New Form 144 - Natera, Inc. Filed: 2025-06-18 AccNo: 0001949846-25-000293 Size: 7 KB

Bioxytran Secures a Source of GMP Quality Camel Hemoglobin

USPTO Files ISSUE NOTIFICATION for BetterLife’s BETR-001 Composition of Matter Patent

Alnylam Announces Promotion of Pushkal Garg to Chief Research and Development Officer

PMGC Capital LLC Urges Alaunos Therapeutics (NASDAQ: TCRT) to Accept Term Sheet from Leading Wall Street Bank Behind Many Leading Crypto Strategies

New Form 144 - Cencora, Inc. Filed: 2025-06-18 AccNo: 0001959173-25-004190 Size: 6 KB

New Form 144 - Ginkgo Bioworks Holdings, Inc. Filed: 2025-06-18 AccNo: 0001959173-25-004188 Size: 44 KB